col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


37 Ergebisse       Seite 1

 [1] 
Elsevier: Genes & Diseases
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Jan―03 Integrative network analysis identifies pivotal host genes and pathways for SARS-CoV-2 infection Gao Chen, Li Li, Ruiqi Wang, Bin Liu, Zhiwen Cao, Ning Zhao, et al. (+4)
2 [GO] 2023―Nov―16 SARS-CoV-2 triggers Dickkopf-1 (Dkk-1) modulation of T helper cells and lung pathology in mice Yifan Wu, Freedom M. Green, Stephen A. Shaw, Lauren J. Bonilla, Shannon E. Ronca, Maria Elena Bottazzi, et al. (+2)
3 [GO] 2023―Okt―28 Efficacy of rapid antigen self-testing for SARS-CoV-2 screening: Real-world evidence from a prospective cohort study Yaoyue Hu, Bin Peng, Jie Fan, Zhu Yang, Jianjiang Xue, Quanxin Long, et al. (+5)
4 [GO] 2023―Sep―27 Effects of COVID-19 pandemic on human fertility: A scientometric and visualized evaluation Xiangxiu Wang, Yifan Rao, Lili Tan, Ziqiu Hu, Lin Wen, Weixi Qin, et al. (+8)
5 [GO] 2023―Sep―09 Neutralization of SARS-CoV-2 infection by antibodies targeting diverse epitopes Shusheng Wang, Yunji Liao, Kaiyong Yang, Hang Ma, Zhangyi Song, Haiqiu Huang, et al. (+12)
6 [GO] 2023―Jun―19 Microbiome and intestinal pathophysiology in post-acute sequelae of COVID-19 Jilei Zhang, Yongguo Zhang, Yinglin Xia, Jun Sun
7 [GO] 2023―Mai―09 Epigenetic regulation of SARS-Cov-2 spike protein modulates cellular viability and nascent RNA transcription in neuronal cells Xi Kong, Peng Lu, Jinyue Zhang, Zheng Bao, Chenghao Kuang, Bingqing Xie, et al. (+4)
8 [GO] 2023―Apr―07 COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery Sunny Kumar, Malini Basu, Pratyasha Ghosh, Uttam Pal, Mrinal K. Ghosh
9 [GO] 2023―Apr―06 Identification of gene classifier and modules associated with SARS-CoV-2 ARI in nasal swab Pandikannan Krishnamoorthy, Athira S. Raj, Himanshu Kumar
10 [GO] 2023―Mrz―27 Circulating fibroblasts present neutrophil-like features in severe COVID-19 cases revealed by single-cell landscape analyses Xiangjun Liu, Jingang Gui, Xiaolin Wang
11 [GO] 2023―Mrz―25 Impact of the COVID-19 pandemic on lung cancer treatment and research Shreya Kailas Lovlekar, Yihua Wang
12 [GO] 2023―Mrz―22 Interaction of piRNA-like sequences from the 3'-UTR of SARS-CoV-2 with mRNA regions Laura Pérez-Campos Mayoral, María Teresa Hernández-Huerta, Carlos Romero Díaz, Carlos Alberto Matias-Cervantes, Eduardo Pérez-Campos Mayoral, Margarito Martínez Cruz, et al. (+4)
13 [GO] 2022―Dez―27 Advances of CRISPR-Cas13 system in COVID-19 diagnosis and treatment Qianqian Zhou, Yanhua Chen, Ruolei Wang, Fengjing Jia, Feng He, Fuwen Yuan
14 [GO] 2022―Nov―29 Weakened humoral and cellular immune response to the inactivated COVID-19 vaccines in Chinese individuals with obesity/overweight Qian Zhu, Yingzhi Zhang, Juan Kang, Zhiwei Chen, Mingli Peng, Min Chen, et al. (+9)
15 [GO] 2022―Sep―23 NSP16 promotes the expression of TMPRSS2 to enhance SARS-CoV-2 cell entry Tianyu Han, Jiapeng Lei, Yang Liu, Yanan Wang, Wenze Xun, Qifan Hu, et al. (+2)
16 [GO] 2022―Sep―08 Single-cell transcriptome landscape and antigen receptor dynamic during SARS-CoV-2 vaccination Xiaojian Cao, Xiaohua Chen, Yaqi Zhu, Xiaojuan Gou, Keyi Yan, Bing Yang, et al. (+4)
17 [GO] 2022―Aug―06 Coronaviruses RNA interacts with host miR-500a-5p and miR-501-5p to regulate multiple pathways Qi Guo, Linghui Tan, Jiajia Pan, Songfang Wu, Jiansong Huang, Fang Yu, Jinghan Wang
18 [GO] 2022―Jun―08 3′-UTR of the SARS-CoV-2 genome as a possible source of piRNAs María Teresa Hernández-Huerta, Laura Pérez-Campos Mayoral, Carlos Alberto Matias-Cervantes, Carlos Romero Díaz, Eli Cruz Parada, Eduardo Pérez-Campos Mayoral, et al. (+4)
19 [GO] 2022―Jun―07 Two human monoclonal SARS-CoV-2 antibodies that maintain neutralizing potency against the SARS-CoV-2 Omicron BA.1 and BA.2 variants Qianqian Zheng, Liangwei Duan, Zhihua Jiang, Tingxuan Gu, Bojie Zhang, Jiaoyang Li, et al. (+4)
20 [GO] 2022―Jan―05 Systematic analysis of clinical relevance and molecular characterization of m6A in COVID-19 patients Sanqi An, Zhouhua Xie, Yanyan Liao, Junjun Jiang, Wenyi Dong, Fuqiang Yin, et al. (+4)
21 [GO] 2021―Dez―03 Reduced neutralization of SARS-CoV-2 B.1.617 variant by convalescent and vaccinated sera Jie Hu, Xiao-yu Wei, Jin Xiang, Pai Peng, Feng-li Xu, Kang Wu, et al. (+7)
22 [GO] 2021―Aug―17 Mediator complex subunit 12 is a gatekeeper of SARS-CoV-2 infection in breast cancer cells Shengjie Zhang, Fabao Liu, Peter Halfmann, Ryan T. Behrens, Peng Liu, Sean J. Mcilwain, et al. (+6)
23 [GO] 2021―Jun―29 Identification of Cross-Reactive CD8+ T Cell Receptors with High Functional Avidity to a SARS-CoV-2 Immunodominant Epitope and Its Natural Mutant Variants Chao Hu, Meiying Shen, Xiaojian Han, Qian Chen, Luo Li, Siyin Chen, et al. (+14)
24 [GO] 2021―Feb―06 A peptide-based assay discriminates individual antibody response to SARS-CoV-2 Immacolata Polvere, Serena Voccola, Gaetano Cardinale, Maurizio Fumi, Francesca Aquila, Alfredina Parrella, et al. (+4)
25 [GO] 2020―Dez―23 Immune characteristics analysis reveals two key inflammatory factors correlated to the expressions of SARS-CoV-2 S1-specific antibodies Shenglong Li, Wang Wang, Tingting Li, Xiaojian Han, Chao Hu, Yingming Wang, et al. (+5)
26 [GO] 2020―Nov―19 Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury Yong Lin, Jun Yuan, Quanxin Long, Jieli Hu, Haijun Deng, Zhenyu Zhao, et al. (+3)
27 [GO] 2020―Sep―06 Gastrointestinal Symptoms, Pathophysiology, and Treatment in COVID-19 Jilei Zhang, Shari Garrett, Jun Sun
28 [GO] 2020―Jul―23 Unclear but present danger: An asymptomatic SARS-CoV-2 carrier Xuejing Yu, Dongchuan Ran, Jinhui Wang, Yuan Qin, Ruishan Liu, Xueli Shi, et al. (+4)
29 [GO] 2020―Jul―17 Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2 Jie Hu, Qingzhu Gao, Changlong He, Ailong Huang, Ni Tang, Kai Wang
30 [GO] 2020―Jul―07 Pandemic COVID-19: current status and challenges of antiviral therapies Winglam Chan, Betsy He, Xiong Wang, Ming-Liang He
31 [GO] 2020―Jun―29 Coronavirus Disease 2019 (COVID-19): Cytokine Storms, Hyper-Inflammatory Phenotypes, and Acute Respiratory Distress Syndrome Shi-hui Lin, Yi-si Zhao, Dai-xing Zhou, Fa-chun Zhou, Fang Xu
32 [GO] 2020―Jun―20 Known drugs and small molecules in the battle for COVID-19 treatment Dr. Alexios A. Panoutsopoulos
33 [GO] 2020―Jun―17 Novel SARS-CoV-2 outbreak and COVID19 disease; a systemic review on the global pandemic Abdulmohsen H. Al-Rohaimi, Faisal Al Otaibi
34 [GO] 2020―Jun―02 Amino acid variation analysis of surface spike glycoprotein at 614 in SARS-CoV-2 strains Canhui Cao, Liang Huang, Kui Liu, Ke Ma, Yuan Tian, Yu Qin, et al. (+4)
35 [GO] 2020―Apr―25 Masks and thermometers: Paramount measures to stop the rapid spread of SARS-CoV-2 in the United States Erxi Wu, Dan Qi
36 [GO] 2020―Apr―14 The clinical and immunological features of pediatric COVID-19 patients in China Juan Chen, Zhen-Zhen Zhang, Yao-Kai Chen, Quan-Xin Long, Wen-Guang Tian, Hai-Jun Deng, et al. (+15)
37 [GO] 2020―Apr―14 Genomics functional analysis and drug screening of SARS-CoV-2 Long Chen, Li Zhong
 [1] 

37 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.015 sec